Fluconazole in the treatment of fungal infections associated with AIDS

Holmberg, K., Meyer, R. D. Fungal infections in patients with AIDS and AIDS-related complex. Scan. J. Infect. Dis. 18 (1986) 179–192.Google Scholar

Centers for Disease Control Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36 (1987) Suppl. 1S pp. 3–15.Google Scholar

Lake-Bakaar, G., Tom, W., Lake-Bakaar, D., Gupta, N., Beidas, S., Elsakr, M., Straus, E. Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 109 (1988) 471–473.Google Scholar

Saag, M. S., Dismukes, W. E. Azole antifungal agents: Emphasis on new triazoles. Antimicrob. Agents Chemother. 32 (1988) 1–8.Google Scholar

Dismukes, W. E. Azoles antifungal drugs: Old and new (Editorial). Ann. Intern. Med. 109 (1988) 177–179.Google Scholar

Selik, R. M., Starcher, T., Curran, J. W. Opportunistic diseases reported in AIDS patients: Frequencies, associations, and trends. AIDS 1 (1987) 175–182.Google Scholar

Clumeck, N., De Wit, S. AIDS in Africa. In:Sande, M. A., Volberding, P. A. (eds.): The medical management of AIDS. W. B. Saunders Company, Philadelphia 1988, pp. 331–349.Google Scholar

Stern, J. J., Hartman, B. J., Sharkey, P., Rowland, V., Squires, K. E., Murray, H. W., Graybill, J. R. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: Experience with 22 patients. Am. J. Med. 85 (1988) 477–480.Google Scholar

Byrne, W. R., Wajszczuk, C. P. Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): Successful treatment with fluconazole after failure of amphotericin B. Ann. Intern. Med. 108 (1988) 384–385.Google Scholar

Sugar, A. M., Saunders, C. Oral fluconazole suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am. J. Med. 85 (1988) 481–489.Google Scholar

Odds, F. C., Webster, C. E. Effects of azole antifungalsin vitro on host/parasite interactions relevant to candida infections. J. Antimicrob. Chemother. 22 (1988) 473–481.Google Scholar

Dupont, B., Drouhet, E.: Fluconazole in the management of oropharyngeal candidiasis in a predominantly HIV antibody-positive group of patients. In:Fromtling, R. A. (ed.): Recent trends in the discovery, development and evaluation of antifungal agents. J. R. Prous Science Publishers 1987.Google Scholar

Meunier, F., Gerain, J., Snoeck, R., Libotte, F., Lambert, C., Ceuppens, A. M.: Fluconazole therapy of oropharyngeal candidiasis in cancer patients. In:Fromtling, R. A. (ed.): Recent trends in the discovery, development and evaluation of antifungal agents. J. R. Prous Science Publishers 1987.Google Scholar

De Wit, S., Weerts, D., Goossens, H., Clumeck, N. Comparison of Fluconazole and Ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1 (1989) 746–747.Google Scholar

Pape, J. W., Liautaud, B., Thomas, F., Mathurin, J. R., St. Amand, M. M. A., Boncy, M., Pean, V., Pamphile, M., Laroche, C., Dehovitz, J., Johnson, W. D. The acquired immunodeficiency syndrome in Haiti. Ann. Intern. Med. 103 (1985) 674–678.Google Scholar

Deschamps, M. M. H., Pape, J. W., Verdier, R. I., De Hovitz, J., Thomas, F., Johnson, W. D. Treatment of candida esophagitis in AIDS patients. Am. J. Gastroenterol. 83 (1988) 20–21.Google Scholar

Van't Wout, J. W., Mattie, H., van Furth, R. A prospective study of the efficacy of Fluconazole (UK-49, 858) against deep-seated fungal infections. J. of Antimicrob. Chemother. 21 (1988) 665–672.Google Scholar

De Wit, S., Weerts, D., Urbain, D., Clumeck, N.: Efficacy of oral Fluconazole in the treatment of oesophageal candidiasis associated with AIDS. Submitted for publication.Google Scholar